3 ms·
> The debate seems to be pretty complex. The debate is complex, but the amyloid plaque people have been steamrollering everybody else into submission--which is
by bsder 6y ago
> The debate seems to be pretty complex.
The debate is complex, but the amyloid plaque people have been steamrollering everybody else into submission--which is unfortunate as their hypothesis has failed every single time it has been put to the test.
However, Big Pharma is no longer backing amyloid plaque research because every single drug targeting them has failed for Alzheimer's.
At this point, it's very likely that amyloid isn't the problem. It's probably a response--and likely one that occurs long after the damage is done.
See Derek Lowe's blog about this stuff:
https://blogs.sciencemag.org/pipeline/archives/2018/06/12/an-alzheimers-statement https://blogs.sciencemag.org/pipeline/archives/2018/06/12/an...
https://blogs.sciencemag.org/pipeline/archives/category/alzheimers-disease https://blogs.sciencemag.org/pipeline/archives/category/alzh...